<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="stated in a credit line to the data. Abstract Coronavirus" exact="disease" post="2019 (COVID-19) has shown high infection and mortality rates"/>
 <result pre="the data. Abstract Coronavirus disease 2019 (COVID-19) has shown high" exact="infection" post="and mortality rates all over the world, and despite"/>
 <result pre="considered the weaker sex in aspects related to endurance and" exact="infection" post="control. Studies show that viral RNA clearance is delayed"/>
 <result pre="aspects related to endurance and infection control. Studies show that" exact="viral" post="RNA clearance is delayed in males with COVID-19. A"/>
 <result pre="the testis can harbor coronavirus, and consequently, males show delayed" exact="viral" post="clearance. However, the role of testis involvement in COVID-19"/>
 <result pre="immune system responses may be a major contributing factor to" exact="viral" post="load, disease severity, and mortality. In addition, differences in"/>
 <result pre="responses may be a major contributing factor to viral load," exact="disease" post="severity, and mortality. In addition, differences in sex hormone"/>
 <result pre="in sex hormone milieus could also be a determinant of" exact="viral" post="infections as estrogen has immunoenhancing effects while testosterone has"/>
 <result pre="sex hormone milieus could also be a determinant of viral" exact="infections" post="as estrogen has immunoenhancing effects while testosterone has immunosuppressive"/>
 <result pre="while testosterone has immunosuppressive effects. The sex-specific severity of COVID-19" exact="infections" post="indicates that further research on understanding the sex differences"/>
 <result pre="information on sex-related differences that may help to better understand" exact="disease" post="outcome and therapy. Keywords Coronavirus Immune system Gender Sex"/>
 <result pre="Stiftelse Funding http://dx.doi.org/10.13039/501100003509Ã–rebro Universitet Introduction In December 2019, a new" exact="pneumonia" post="outbreak emerged in Wuhan, Hubei province, China, which showed"/>
 <result pre="outbreak emerged in Wuhan, Hubei province, China, which showed high" exact="infection" post="rate and mortality. Similar to severe acute respiratory syndrome"/>
 <result pre="which showed high infection rate and mortality. Similar to severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV), patients displayed symptoms of pneumonia"/>
 <result pre="showed high infection rate and mortality. Similar to severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV), patients displayed symptoms of pneumonia [1,"/>
 <result pre="high infection rate and mortality. Similar to severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV), patients displayed symptoms of pneumonia [1, 2]."/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV), patients displayed symptoms of" exact="pneumonia" post="[1, 2]. Later, the Chinese Center for Disease Control"/>
 <result pre="symptoms of pneumonia [1, 2]. Later, the Chinese Center for" exact="Disease" post="Control and Prevention (CDC) identified that this disease was"/>
 <result pre="Center for Disease Control and Prevention (CDC) identified that this" exact="disease" post="was caused by coronavirus and it was classified as"/>
 <result pre="it was classified as 2019 novel coronavirus (2019-nCoV), and the" exact="disease" post="was named coronavirus disease 2019 (COVID-2019). The virus was"/>
 <result pre="2019 novel coronavirus (2019-nCoV), and the disease was named coronavirus" exact="disease" post="2019 (COVID-2019). The virus was renamed by the International"/>
 <result pre="by the International Committee on Taxonomy of Viruses as severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2) [3]. The World Health Organization"/>
 <result pre="the International Committee on Taxonomy of Viruses as severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2) [3]. The World Health Organization (WHO)"/>
 <result pre="International Committee on Taxonomy of Viruses as severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2) [3]. The World Health Organization (WHO) declared"/>
 <result pre="and it resulted in 774 deaths. In 2012, Middle East" exact="respiratory" post="syndrome (MERS) which first emerged in Saudi Arabia resulted"/>
 <result pre="it resulted in 774 deaths. In 2012, Middle East respiratory" exact="syndrome" post="(MERS) which first emerged in Saudi Arabia resulted in"/>
 <result pre="deaths [4]. The SARS-CoV-2 is mainly transmitted from person-to-person via" exact="respiratory" post="droplets, and the clinical features of COVID-19 range from"/>
 <result pre="droplets, and the clinical features of COVID-19 range from asymptomatic" exact="respiratory" post="infections to severe pneumonia [5]. The most common symptoms"/>
 <result pre="and the clinical features of COVID-19 range from asymptomatic respiratory" exact="infections" post="to severe pneumonia [5]. The most common symptoms are"/>
 <result pre="features of COVID-19 range from asymptomatic respiratory infections to severe" exact="pneumonia" post="[5]. The most common symptoms are fever, fatigue, dry"/>
 <result pre="[6, 7]. Patients with underlying comorbidities including diabetes, hypertension, and" exact="cardiovascular disease" post="in both young and older individuals show more severe"/>
 <result pre="7]. Patients with underlying comorbidities including diabetes, hypertension, and cardiovascular" exact="disease" post="in both young and older individuals show more severe"/>
 <result pre="that were designed for other diseases including HIV, Ebola, and" exact="malaria" post="have been tested to treat COVID-19 [3]. The lack"/>
 <result pre="also showed male-biased mortality [8]. The confirmed cases of SARS-CoV-2" exact="infections" post="differed across the age groups between males and females."/>
 <result pre="10 and after 50â€‰years were more susceptible [9]. Analysis of" exact="viral" post="RNA in COVID-19 patients indicated that the males show"/>
 <result pre="RNA in COVID-19 patients indicated that the males show delayed" exact="viral" post="clearance as the SARS-CoV-2 RNA was detected for a"/>
 <result pre="Understanding of sex differences could further help in understanding the" exact="disease" post="outcome and therapeutics for COVID-19 and other new emerging"/>
 <result pre="as of July 24 for Sweden was taken from the" exact="Swedish" post="Public Health Agency Coronavirus infection and therapeutic targets Coronaviruses"/>
 <result pre="Sweden was taken from the Swedish Public Health Agency Coronavirus" exact="infection" post="and therapeutic targets Coronaviruses are pleomorphic, enveloped, single positive"/>
 <result pre="are pleomorphic, enveloped, single positive stranded RNA virus [12]. The" exact="viral" post="membrane contains transmembrane (M) glycoprotein, spike (S) glycoprotein, and"/>
 <result pre="forms the coronal fringe around the virus, and it facilitates" exact="viral" post="entry into human cells [13, 14] (Fig. 2). The"/>
 <result pre="S1/S2, S2 cleavage site, and given its important role in" exact="viral" post="entry, TMPRSS2 is considered a potential therapeutic target to"/>
 <result pre="TMPRSS2 is considered a potential therapeutic target to control coronavirus" exact="infection" post="[14]. TMPRSS2 inhibitors including nafamostat and camostat are undergoing"/>
 <result pre="form can bind to virus and can help to prevent" exact="infection" post="Fig. 3 Spike protein of coronavirus. The schematic diagram"/>
 <result pre="S1/S2 and S2â€²cleavage sites are acted by protease to assist" exact="viral" post="fusion. RBM sequence between SARS-CoV and SARS-CoV-2 showed 46.5%"/>
 <result pre="[25, 26]. In the lungs, ACE2 is mainly expressed in" exact="type I" post="and type II alveolar epithelial cells [25]; however, its"/>
 <result pre="the lungs, ACE2 is mainly expressed in type I and" exact="type II" post="alveolar epithelial cells [25]; however, its function in the"/>
 <result pre="is mainly expressed in type I and type II alveolar" exact="epithelial" post="cells [25]; however, its function in the lungs is"/>
 <result pre="ACE2 is an X chromosome encoded gene, the presence of" exact="disease" post="or risk variants in men will be more detrimental"/>
 <result pre="ACE2 variants can affect the COVID-19 pathogenesis. In patients with" exact="heart" post="diseases, the level of plasma ACE2 is high [33]"/>
 <result pre="its expression levels do not correlate with the degree of" exact="infection" post="and viral load [34]. The equilibrium between soluble and"/>
 <result pre="levels do not correlate with the degree of infection and" exact="viral" post="load [34]. The equilibrium between soluble and membrane-bound ACE2"/>
 <result pre="[5]. An inÂ vitro study showed that human coronavirus (HCoV-NL63)" exact="infection" post="can downregulate ACE2 [37] and similar findings were observed"/>
 <result pre="downregulate ACE2 [37] and similar findings were observed with SARS-CoV" exact="infections" post="in mice model [38]. The reduced ACE2 levels following"/>
 <result pre="in mice model [38]. The reduced ACE2 levels following SARS-CoV" exact="infection" post="led to acute lung injury, and interestingly, the lung"/>
 <result pre="[38]. The reduced ACE2 levels following SARS-CoV infection led to" exact="acute" post="lung injury, and interestingly, the lung injury was significantly"/>
 <result pre="was significantly attenuated in ACE2 knockout mice and angiotensin II" exact="type 1" post="receptor blocker (ARB) treated groups [38]. In animal models,"/>
 <result pre="are high in men compared to women in patients with" exact="heart" post="failure [33]. However, the use of ACE inhibitors and"/>
 <result pre="as a decoy receptor to bind SARS-CoV-2 and reduce the" exact="viral" post="load and infection [5]. The rhACE2 was considered for"/>
 <result pre="receptor to bind SARS-CoV-2 and reduce the viral load and" exact="infection" post="[5]. The rhACE2 was considered for SARS-CoV treatment [38],"/>
 <result pre="vulnerable than females. Males show higher mortality from diseases including" exact="heart" post="disease, diabetes, liver disease, and cancer [42]. Since these"/>
 <result pre="Males show higher mortality from diseases including heart disease, diabetes," exact="liver disease," post="and cancer [42]. Since these diseases are known to"/>
 <result pre="mortality from diseases including heart disease, diabetes, liver disease, and" exact="cancer" post="[42]. Since these diseases are known to show sex-specific"/>
 <result pre="is suggested to be due to a higher prevalence of" exact="cardiovascular" post="diseases in Italian men [6]. The differences between males"/>
 <result pre="differences between males and females are observed not only in" exact="disease" post="susceptibility but also in early development during infancy, endurance"/>
 <result pre="conditions are low in males compared to females. The freed" exact="American" post="slavesâ€™ journey back to Africa in 1820â€&quot;1843 resulted in"/>
 <result pre="was 1.68â€‰years for males and 2.23â€‰years for females [46]. The" exact="measles" post="outbreak in Iceland (1845â€&quot;1849) also showed sex-specific mortality. The"/>
 <result pre="the great recession of 2007 also resulted in decreased male" exact="childbirth" post="[49, 50]. Taken together, it can be suggested that"/>
 <result pre="50]. Taken together, it can be suggested that males have" exact="lower" post="endurance levels than females. The sex-related difference in the"/>
 <result pre="males in stressful conditions including COVID-19. Immune system differences and" exact="viral infection" post="Sex differences result in differential regulation of innate and"/>
 <result pre="in stressful conditions including COVID-19. Immune system differences and viral" exact="infection" post="Sex differences result in differential regulation of innate and"/>
 <result pre="and females show differences in immune response when challenged with" exact="viral" post="infections. For instance, in acute HIV infected cases, females"/>
 <result pre="immune response when challenged with viral infections. For instance, in" exact="acute" post="HIV infected cases, females show 40% less viral RNA"/>
 <result pre="instance, in acute HIV infected cases, females show 40% less" exact="viral" post="RNA than males, and hepatitis virus shows higher mortality"/>
 <result pre="cases, females show 40% less viral RNA than males, and" exact="hepatitis" post="virus shows higher mortality in men [51]. Furthermore, there"/>
 <result pre="in men [51]. Furthermore, there are many bacterial, fungal, and" exact="viral" post="diseases that show sex-biased infections. Treponema pallidum (syphilis), Borrelia"/>
 <result pre="and viral diseases that show sex-biased infections. Treponema pallidum (syphilis)," exact="Borrelia" post="burgdorferi (Lyme disease), Cryptococcus neoformans (fungal meningitis), influenza A"/>
 <result pre="(Lyme disease), Cryptococcus neoformans (fungal meningitis), influenza A (influenza), and" exact="hepatitis C" post="(hepatitis) infections are common in males while Candida albicans"/>
 <result pre="neoformans (fungal meningitis), influenza A (influenza), and hepatitis C (hepatitis)" exact="infections" post="are common in males while Candida albicans (onchomycosis), Escherichia"/>
 <result pre="while Candida albicans (onchomycosis), Escherichia coli (bacteremias), and Taenia (tapeworm)" exact="infections" post="are common in females [52]. COVID-19 has also shown"/>
 <result pre="Immune-related diseases show sex-specific incidences, for instance, most of the" exact="autoimmune diseases" post="including rheumatoid arthritis, systemic lupus erythematosus, SjÃ¶gren syndrome, myasthenia"/>
 <result pre="sex-specific incidences, for instance, most of the autoimmune diseases including" exact="rheumatoid arthritis," post="systemic lupus erythematosus, SjÃ¶gren syndrome, myasthenia gravis, and multiple"/>
 <result pre="for instance, most of the autoimmune diseases including rheumatoid arthritis," exact="systemic" post="lupus erythematosus, SjÃ¶gren syndrome, myasthenia gravis, and multiple sclerosis"/>
 <result pre="instance, most of the autoimmune diseases including rheumatoid arthritis, systemic" exact="lupus erythematosus," post="SjÃ¶gren syndrome, myasthenia gravis, and multiple sclerosis are prevalent"/>
 <result pre="autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, SjÃ¶gren syndrome," exact="myasthenia gravis," post="and multiple sclerosis are prevalent in females [51, 55]."/>
 <result pre="rheumatoid arthritis, systemic lupus erythematosus, SjÃ¶gren syndrome, myasthenia gravis, and" exact="multiple sclerosis" post="are prevalent in females [51, 55]. Females show higher"/>
 <result pre="females [56â€&quot;58]. For instance, the protective antibody responses against the" exact="measles" post="vaccine were twice as high in females compared to"/>
 <result pre="been observed with other vaccines including rubella, hepatitis, rabies, mumps," exact="yellow fever," post="and influenza [57]. Although females respond better to vaccination,"/>
 <result pre="Sex chromosome constitution could also play an important role in" exact="disease" post="outcome. Females have two copies of X chromosomes while"/>
 <result pre="have been shown to provide protection against virus by recognizing" exact="viral" post="RNA and DNA while TLR2 and TLR4 provide protection"/>
 <result pre="al. highlighted important sex differences in immune responses using human" exact="peripheral" post="blood mononuclear cells (PBMCs). The authors showed that genomic"/>
 <result pre="IL-6, IL-12, IFNÎ³, putative internal head protein 10 (IP10), and" exact="monocyte" post="chemoattractant protein 1 (MCP1) were increased in SARS-CoV patients"/>
 <result pre="IL-7, IL-10, granulocyte stimulating factor, interferon Î³ inducible protein 10," exact="monocyte" post="chemoattractant protein 1, macrophage inflammatory protein 1-Î±, and tumor"/>
 <result pre="10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-Î±, and" exact="tumor" post="necrosis factor Î± were increased [2, 66, 67]. Among"/>
 <result pre="defensin, DNA, RNA, F-actin, and HMGB1 have been identified [70]." exact="Increased" post="level of HMGB1 can induce proinflammatory cytokine (TNF, IL-1,"/>
 <result pre="induce proinflammatory cytokine (TNF, IL-1, and IL-6) release, and since" exact="chronic" post="inflammatory diseases result in HMGB1 increase, the severity in"/>
 <result pre="can lead to differential mode of action to clear the" exact="viral" post="load and damaged cells. Stressed pulmonary endothelial cells in"/>
 <result pre="action to clear the viral load and damaged cells. Stressed" exact="pulmonary" post="endothelial cells in males are known to undergo necrosis"/>
 <result pre="indicates that HMGB1 levels are differentially regulated in male and" exact="female" post="COVID-19 patients with higher levels in males that further"/>
 <result pre="the severity and high mortality in males. Sex hormones and" exact="viral infection" post="Gonadal hormones not only are involved in the differentiation"/>
 <result pre="severity and high mortality in males. Sex hormones and viral" exact="infection" post="Gonadal hormones not only are involved in the differentiation"/>
 <result pre="organs, but also exert sex-specific regulation to multiple tissues including" exact="brain" post="and those of the immune system [52, 72, 73]."/>
 <result pre="male reproductive systems. Testosterone is also suggested to reach the" exact="brain" post="and organize neuronal networks. Testosterone can mediate gene expression"/>
 <result pre="Testosterone is also suggested to reach the brain and organize" exact="neuronal" post="networks. Testosterone can mediate gene expression directly by binding"/>
 <result pre="there was no difference in ER expression in male and" exact="female" post="T and B cells, the authors argued that the"/>
 <result pre="were higher in male hematopoietic stem cells (HSCs) than in" exact="female" post="HSCs and that the level of ERÎ² was low"/>
 <result pre="the level of ERÎ² was low in both male and" exact="female" post="HSCs. The authors also found that HSCs in females"/>
 <result pre="T helper cell differentiation [81] and positively correlate with the" exact="viral" post="load of Venezuelan equine encephalitis virus in macaques [82]."/>
 <result pre="differentiation [81] and positively correlate with the viral load of" exact="Venezuelan equine encephalitis" post="virus in macaques [82]. Testosterone is also known to"/>
 <result pre="and positively correlate with the viral load of Venezuelan equine" exact="encephalitis" post="virus in macaques [82]. Testosterone is also known to"/>
 <result pre="that the level is usually low in females suffering from" exact="autoimmune disease" post="compared to healthy females [55]. Furthermore, androgen ablation in"/>
 <result pre="the level is usually low in females suffering from autoimmune" exact="disease" post="compared to healthy females [55]. Furthermore, androgen ablation in"/>
 <result pre="in male mice showed improved performance of immune cells towards" exact="prostate cancer" post="[84]. Androgen ablation also alters immune organs as the"/>
 <result pre="male mice showed improved performance of immune cells towards prostate" exact="cancer" post="[84]. Androgen ablation also alters immune organs as the"/>
 <result pre="have been reported to increase weight [85]. Although the mature" exact="peripheral" post="CD4 T cell population declined, the one that reached"/>
 <result pre="susceptibility and severity towards pathogenic infections. It is indicated that" exact="prostate cancer" post="patients who are under androgen-deprivation therapy (ADT) to regulate"/>
 <result pre="and severity towards pathogenic infections. It is indicated that prostate" exact="cancer" post="patients who are under androgen-deprivation therapy (ADT) to regulate"/>
 <result pre="(ADT) to regulate androgen production have lowered risk for SARS-CoV-2" exact="infection" post="compared with patients who did not receive ADT [86]."/>
 <result pre="that ADT could be beneficial for COVID-19, and since this" exact="disease" post="progresses rapidly, the ADT intervention will be beneficial during"/>
 <result pre="ADT intervention will be beneficial during the initial stage of" exact="viral infection" post="and not in later stages [88]. However, the expression"/>
 <result pre="intervention will be beneficial during the initial stage of viral" exact="infection" post="and not in later stages [88]. However, the expression"/>
 <result pre="[88]. However, the expression of TMPRSS2 in human male and" exact="female" post="lungs is not different [89, 90], and in mice"/>
 <result pre="with enzalutamide, an AR antagonist, did not result in decreased" exact="pulmonary" post="TMPRSS2 expression [89]. Hence, the use of AR antagonists"/>
 <result pre="protection against pathogens as it has antiviral properties in different" exact="viral" post="infections including HIV, hepatitis C virus, Ebola, and human"/>
 <result pre="against pathogens as it has antiviral properties in different viral" exact="infections" post="including HIV, hepatitis C virus, Ebola, and human cytomegalovirus"/>
 <result pre="it has antiviral properties in different viral infections including HIV," exact="hepatitis C" post="virus, Ebola, and human cytomegalovirus [91]. Estrogen was shown"/>
 <result pre="shown to inhibit influenza A virus replication in cultured nasal" exact="epithelial" post="cells isolated from female mice [91]. Interestingly, the protective"/>
 <result pre="A virus replication in cultured nasal epithelial cells isolated from" exact="female" post="mice [91]. Interestingly, the protective effect of estrogen was"/>
 <result pre="the protective effect of estrogen was not observed in nasal" exact="epithelial" post="cells isolated from male mice [91]. Since SARS predominantly"/>
 <result pre="estrogen levels in females may increase the protection from SARS" exact="infections" post="[63]. Inhibition of ER function using ER antagonist ICI"/>
 <result pre="function using ER antagonist ICI 182,780 resulted in higher SARS-CoV" exact="infections" post="in females. However, gonadectomy or treatment with the AR"/>
 <result pre="not affect morbidity or mortality in male mice following SARS-CoV" exact="infection" post="[63]. Based on this, it was suggested that the"/>
 <result pre="the estrogen receptor signaling plays an important role in coronavirus" exact="infection" post="and mortality, while androgens do not play a role"/>
 <result pre="[63]. This suggests that estrogen signaling is critical in regulating" exact="viral infection" post="and could be one of the reasons why females"/>
 <result pre="This suggests that estrogen signaling is critical in regulating viral" exact="infection" post="and could be one of the reasons why females"/>
 <result pre="showing fast recovery and low mortality from COVID-19. Testis and" exact="viral" post="clearance The testis is an immune-privileged organ as both"/>
 <result pre="meiotic germ cell antigen (MGCA), and this can result in" exact="infertility" post="[92]. Although testis is an immune-privileged organ, it can"/>
 <result pre="microbial pathogens infiltrate the organ. Viruses including HIV, cytomegalovirus, and" exact="mumps" post="are known to infect testis and lead to testicular"/>
 <result pre="coronavirus can enter the testis and consequently lead to higher" exact="viral" post="load and take more time for viral clearance. The"/>
 <result pre="lead to higher viral load and take more time for" exact="viral" post="clearance. The total subjects in this study was only"/>
 <result pre="viral load and take more time for viral clearance. The" exact="total" post="subjects in this study was only 68 (48 males"/>
 <result pre="testis. The sex hormones in males were also altered following" exact="infection" post="with SARS-CoV-2. Analysis of 81 infected men with SARS-CoV-2"/>
 <result pre="[97]. Although coronavirus RNA was detected in semen samples, active" exact="viral" post="particles have not been isolated from testis so far."/>
 <result pre="far. Hence, the theory of involvement of testis in delayed" exact="viral" post="clearance and high mortality in men [26] should be"/>
 <result pre="spermatozoon, thickened basement membrane, and leukocyte infiltration [98]. However, no" exact="viral" post="particles or viral RNA was detected in the tissue"/>
 <result pre="membrane, and leukocyte infiltration [98]. However, no viral particles or" exact="viral" post="RNA was detected in the tissue samples and it"/>
 <result pre="response to pathogens which could help them to better regulate" exact="viral" post="load and viral clearance compared with males. Since many"/>
 <result pre="which could help them to better regulate viral load and" exact="viral" post="clearance compared with males. Since many immune genes are"/>
 <result pre="immune response. The robust immune system in females better regulates" exact="viral" post="infections, and consequently, lower mortality is observed. The stress"/>
 <result pre="immune system in females better regulates viral infections, and consequently," exact="lower" post="mortality is observed. The stress endurance level is low"/>
 <result pre="differences associated with physiology, immune function, and developmental processes. Fewer" exact="female" post="animals are used in research and clinical trials and"/>
 <result pre="2 ADT Androgen-deprivation therapy AR Androgen receptor ARB Angiotensin II" exact="type 1" post="receptor blocker ER Estrogen receptor COVID-19 Coronavirus disease 19"/>
 <result pre="II type 1 receptor blocker ER Estrogen receptor COVID-19 Coronavirus" exact="disease" post="19 DAMP Damage-associated molecular pattern molecule HMGB1 High mobility"/>
 <result pre="HSC Hematopoietic stem cell NTD N-terminal domain MERS Middle East" exact="respiratory" post="syndrome MGCA Meiotic germ cell antigen RBD Receptor binding"/>
 <result pre="Hematopoietic stem cell NTD N-terminal domain MERS Middle East respiratory" exact="syndrome" post="MGCA Meiotic germ cell antigen RBD Receptor binding domain"/>
 <result pre="MGCA Meiotic germ cell antigen RBD Receptor binding domain SARS" exact="Severe" post="acute respiratory syndrome coronavirus SRY Sex determining region Y"/>
 <result pre="Meiotic germ cell antigen RBD Receptor binding domain SARS Severe" exact="acute" post="respiratory syndrome coronavirus SRY Sex determining region Y TMPRSS2"/>
 <result pre="germ cell antigen RBD Receptor binding domain SARS Severe acute" exact="respiratory" post="syndrome coronavirus SRY Sex determining region Y TMPRSS2 Transmembrane"/>
 <result pre="cell antigen RBD Receptor binding domain SARS Severe acute respiratory" exact="syndrome" post="coronavirus SRY Sex determining region Y TMPRSS2 Transmembrane protease/serine"/>
 <result pre="manuscript. Funding This study was supported by the following: the" exact="Swedish" post="Research Council (2019-04455)â€&quot;data analysis and manuscript writing; the Knowledge"/>
 <result pre="Piemonti L. Gender and age effects on the rates of" exact="infection" post="and deaths in individuals with confirmed sars-cov-2 infection in"/>
 <result pre="rates of infection and deaths in individuals with confirmed sars-cov-2" exact="infection" post="in six european countries. Lancet. 2020. 10.Xu K, Chen"/>
 <result pre="Ding C, Wu W, et al. Factors associated with prolonged" exact="viral" post="RNA shedding in patients with coronavirus disease 2019 (covid-19)."/>
 <result pre="associated with prolonged viral RNA shedding in patients with coronavirus" exact="disease" post="2019 (covid-19). Clin Infect Dis. 2020. 11.ZhengSFanJYuFFengBLouBZouQet al.Viral load"/>
 <result pre="(covid-19). Clin Infect Dis. 2020. 11.ZhengSFanJYuFFengBLouBZouQet al.Viral load dynamics and" exact="disease" post="severity in patients infected with sars-cov-2 in Zhejiang Province,"/>
 <result pre="replication and pathogenesisNat Rev Microbiol2009743945019430490 13.NeumanBWAdairBDYoshiokaCQuispeJDOrcaGKuhnPet al.Supramolecular architecture of severe" exact="acute" post="respiratory syndrome coronavirus revealed by electron cryomicroscopyJ Virol2006807918792816873249 14.HoffmannMKleine-WeberHSchroederSKrugerNHerrlerTErichsenSet"/>
 <result pre="and pathogenesisNat Rev Microbiol2009743945019430490 13.NeumanBWAdairBDYoshiokaCQuispeJDOrcaGKuhnPet al.Supramolecular architecture of severe acute" exact="respiratory" post="syndrome coronavirus revealed by electron cryomicroscopyJ Virol2006807918792816873249 14.HoffmannMKleine-WeberHSchroederSKrugerNHerrlerTErichsenSet al.Sars-cov-2"/>
 <result pre="pathogenesisNat Rev Microbiol2009743945019430490 13.NeumanBWAdairBDYoshiokaCQuispeJDOrcaGKuhnPet al.Supramolecular architecture of severe acute respiratory" exact="syndrome" post="coronavirus revealed by electron cryomicroscopyJ Virol2006807918792816873249 14.HoffmannMKleine-WeberHSchroederSKrugerNHerrlerTErichsenSet al.Sars-cov-2 cell"/>
 <result pre="is a functional receptor for the sars coronavirusNature200342645045414647384 16.ZhouPYangXLWangXGHuBZhangLZhangWet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="probable bat originNature202057927027332015507 17.GlowackaIBertramSMullerMAAllenPSoilleuxEPfefferleSet al.Evidence that tmprss2 activates the severe" exact="acute" post="respiratory syndrome coronavirus spike protein for membrane fusion and"/>
 <result pre="bat originNature202057927027332015507 17.GlowackaIBertramSMullerMAAllenPSoilleuxEPfefferleSet al.Evidence that tmprss2 activates the severe acute" exact="respiratory" post="syndrome coronavirus spike protein for membrane fusion and reduces"/>
 <result pre="originNature202057927027332015507 17.GlowackaIBertramSMullerMAAllenPSoilleuxEPfefferleSet al.Evidence that tmprss2 activates the severe acute respiratory" exact="syndrome" post="coronavirus spike protein for membrane fusion and reduces viral"/>
 <result pre="respiratory syndrome coronavirus spike protein for membrane fusion and reduces" exact="viral" post="control by the humoral immune responseJ Virol2011854122413421325420 18.ShullaAHeald-SargentTSubramanyaGZhaoJCPerlmanSGallagherTA transmembrane"/>
 <result pre="Virol2011854122413421325420 18.ShullaAHeald-SargentTSubramanyaGZhaoJCPerlmanSGallagherTA transmembrane serine protease is linked to the severe" exact="acute" post="respiratory syndrome coronavirus receptor and activates virus entryJ Virol20118587388221068237"/>
 <result pre="18.ShullaAHeald-SargentTSubramanyaGZhaoJCPerlmanSGallagherTA transmembrane serine protease is linked to the severe acute" exact="respiratory" post="syndrome coronavirus receptor and activates virus entryJ Virol20118587388221068237 19.Tai"/>
 <result pre="transmembrane serine protease is linked to the severe acute respiratory" exact="syndrome" post="coronavirus receptor and activates virus entryJ Virol20118587388221068237 19.Tai WB,"/>
 <result pre="novel coronavirus: implication for development of RBD protein as a" exact="viral" post="attachment inhibitor and vaccine. Cell Mol Immunol. 2020. 20.LanJGeJYuJShanSZhouHFanSet"/>
 <result pre="Agrawal S, Chaterjee N, Pradhan K, Goldfinger M, et al." exact="Delayed" post="clearance of sars-cov2 in male compared to female patients:"/>
 <result pre="et al. Delayed clearance of sars-cov2 in male compared to" exact="female" post="patients: high ace2 expression in testes suggests possible existence"/>
 <result pre="in male compared to female patients: high ace2 expression in" exact="testes" post="suggests possible existence of gender-specific viral reservoirs. MedRxiv. 2020;"/>
 <result pre="high ace2 expression in testes suggests possible existence of gender-specific" exact="viral" post="reservoirs. MedRxiv. 2020; 2020.2004.2016.20060566. 27.ImaiYKubaKRaoSHuanYGuoFGuanBet al.Angiotensin-converting enzyme 2 protects"/>
 <result pre="MedRxiv. 2020; 2020.2004.2016.20060566. 27.ImaiYKubaKRaoSHuanYGuoFGuanBet al.Angiotensin-converting enzyme 2 protects from severe" exact="acute" post="lung failureNature200543611211616001071 28.HeurichAHofmann-WinklerHGiererSLiepoldTJahnOPohlmannSTmprss2 and adam17 cleave ace2 differentially and"/>
 <result pre="only proteolysis by tmprss2 augments entry driven by the severe" exact="acute" post="respiratory syndrome coronavirus spike proteinJ Virol2014881293130724227843 29.LambertBWLambertLAClarkeNEHooperNMPorterKETurnerAJAngiotensin-converting enzyme 2"/>
 <result pre="proteolysis by tmprss2 augments entry driven by the severe acute" exact="respiratory" post="syndrome coronavirus spike proteinJ Virol2014881293130724227843 29.LambertBWLambertLAClarkeNEHooperNMPorterKETurnerAJAngiotensin-converting enzyme 2 is"/>
 <result pre="by tmprss2 augments entry driven by the severe acute respiratory" exact="syndrome" post="coronavirus spike proteinJ Virol2014881293130724227843 29.LambertBWLambertLAClarkeNEHooperNMPorterKETurnerAJAngiotensin-converting enzyme 2 is subject"/>
 <result pre="of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with" exact="essential hypertension" post="in different gender: a case-control studyMedicine (Baltimore)201897e1291730335025 33.SamaIERaveraASantemaBTvan GoorHter"/>
 <result pre="angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential" exact="hypertension" post="in different gender: a case-control studyMedicine (Baltimore)201897e1291730335025 33.SamaIERaveraASantemaBTvan GoorHter"/>
 <result pre="concentrations of angiotensin-converting enzyme 2 in men and women with" exact="heart" post="failure and effects of reninâ€&quot;angiotensinâ€&quot;aldosterone inhibitorsEur Heart J2020411810181732388565 34.KusterGMPfisterOBurkardTZhouQTwerenboldRHaafPet"/>
 <result pre="and women with heart failure and effects of reninâ€&quot;angiotensinâ€&quot;aldosterone inhibitorsEur" exact="Heart" post="J2020411810181732388565 34.KusterGMPfisterOBurkardTZhouQTwerenboldRHaafPet al.Sars-cov2: should inhibitors of the reninâ€&quot;angiotensin system"/>
 <result pre="of the reninâ€&quot;angiotensin system be withdrawn in patients with covid-19?Eur" exact="Heart" post="J2020411801180332196087 35.CrackowerMASaraoROuditGYYagilCKozieradzkiIScangaSEet al.Angiotensin-converting enzyme 2 is an essential regulator"/>
 <result pre="J2020411801180332196087 35.CrackowerMASaraoROuditGYYagilCKozieradzkiIScangaSEet al.Angiotensin-converting enzyme 2 is an essential regulator of" exact="heart" post="functionNature200241782282812075344 36.OcaranzaMPRiquelmeJAGarcÃ­aLJalilJEChiongMSantosRAet al.Counter-regulatory reninâ€&quot;angiotensin system in cardiovascular diseaseNat Rev"/>
 <result pre="essential regulator of heart functionNature200241782282812075344 36.OcaranzaMPRiquelmeJAGarcÃ­aLJalilJEChiongMSantosRAet al.Counter-regulatory reninâ€&quot;angiotensin system in" exact="cardiovascular" post="diseaseNat Rev Cardiol20191711612931427727 37.DijkmanRJebbinkMFDeijsMMilewskaAPyrcKBuelowEet al.Replication-dependent downregulation of cellular angiotensin-converting"/>
 <result pre="Deaths: leading causes for 2017. CDC. 2019;68. 43.DorakMTKarpuzogluEGender differences in" exact="cancer" post="susceptibility: an inadequately addressed issueFront Genet2012326823226157 44.WakabayashiIGender differences in"/>
 <result pre="cancer susceptibility: an inadequately addressed issueFront Genet2012326823226157 44.WakabayashiIGender differences in" exact="cardiovascular" post="risk factors in patients with coronary artery disease and"/>
 <result pre="Genet2012326823226157 44.WakabayashiIGender differences in cardiovascular risk factors in patients with" exact="coronary artery disease" post="and those with type 2 diabetesJ Thorac Dis20179E503E50628616322 45.KraemerSThe"/>
 <result pre="44.WakabayashiIGender differences in cardiovascular risk factors in patients with coronary" exact="artery disease" post="and those with type 2 diabetesJ Thorac Dis20179E503E50628616322 45.KraemerSThe"/>
 <result pre="differences in cardiovascular risk factors in patients with coronary artery" exact="disease" post="and those with type 2 diabetesJ Thorac Dis20179E503E50628616322 45.KraemerSThe"/>
 <result pre="factors in patients with coronary artery disease and those with" exact="type 2" post="diabetesJ Thorac Dis20179E503E50628616322 45.KraemerSThe fragile maleBMJ20003211609161211124200 46.ZarulliVJonesJABOksuzyanALindahl-JacobsenRChristensenKVaupelJWWomen live longer"/>
 <result pre="recession of 2007 in the United States and the male:" exact="female" post="ratio at birthJ Turk Ger Gynecol Assoc201516707326097387 51.KleinSLFlanaganKLSex differences"/>
 <result pre="CJ, Moller M. The x chromosome and sex-specific effects in" exact="infectious disease" post="susceptibility. Hum Genomics. 2019;13. 53.HewagamaAPatelDYarlagaddaSStricklandFMRichardsonBCStronger inflammatory/cytotoxic t-cell response in"/>
 <result pre="Moller M. The x chromosome and sex-specific effects in infectious" exact="disease" post="susceptibility. Hum Genomics. 2019;13. 53.HewagamaAPatelDYarlagaddaSStricklandFMRichardsonBCStronger inflammatory/cytotoxic t-cell response in"/>
 <result pre="Endocrin Rev199617369384 56.KleinSLJedlickaAPekoszAThe xs and y of immune responses to" exact="viral" post="vaccinesLancet Infect Dis20101033834920417416 57.KleinSLMarriottIFishENSex-based differences in immune function and"/>
 <result pre="variables and multiple measles-specific innate and cell-mediated immune responses after" exact="measles" post="vaccinationViral Immunol201225293622239234 59.LeeBWYapHKChewFTQuahTCPrabhakaranKChanGSHet al.Age- and sex-related changes in lymphocyte"/>
 <result pre="men in the Japanese populationImmun Ageing2013101923675689 63.ChannappanavarRFettCMackMTen EyckPPMeyerholzDKPerlmanSSex-based differences in" exact="susceptibility to" post="severe acute respiratory syndrome coronavirus infectionJ Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma"/>
 <result pre="Japanese populationImmun Ageing2013101923675689 63.ChannappanavarRFettCMackMTen EyckPPMeyerholzDKPerlmanSSex-based differences in susceptibility to severe" exact="acute" post="respiratory syndrome coronavirus infectionJ Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma inflammatory cytokines"/>
 <result pre="populationImmun Ageing2013101923675689 63.ChannappanavarRFettCMackMTen EyckPPMeyerholzDKPerlmanSSex-based differences in susceptibility to severe acute" exact="respiratory" post="syndrome coronavirus infectionJ Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma inflammatory cytokines and"/>
 <result pre="Ageing2013101923675689 63.ChannappanavarRFettCMackMTen EyckPPMeyerholzDKPerlmanSSex-based differences in susceptibility to severe acute respiratory" exact="syndrome" post="coronavirus infectionJ Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma inflammatory cytokines and chemokines"/>
 <result pre="infectionJ Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma inflammatory cytokines and chemokines in severe" exact="acute" post="respiratory syndromeClin Exp Immunol20041369510315030519 65.Mahallawi WH, Khabour OF, Zhang"/>
 <result pre="Immunol20171984046405328373583 64.WongCLamCWuAIpWLeeNChanIet al.Plasma inflammatory cytokines and chemokines in severe acute" exact="respiratory" post="syndromeClin Exp Immunol20041369510315030519 65.Mahallawi WH, Khabour OF, Zhang Q,"/>
 <result pre="WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BAJC. MERS-cov" exact="infection" post="in humans is associated with a pro-inflammatory th1 and"/>
 <result pre="Xiang YF. Can we use interleukin-6 (il-6) blockade for coronavirus" exact="disease" post="2019 (covid-19)-induced cytokine release syndrome (crs)? J Autoimmun. 2020;111."/>
 <result pre="interleukin-6 (il-6) blockade for coronavirus disease 2019 (covid-19)-induced cytokine release" exact="syndrome" post="(crs)? J Autoimmun. 2020;111. 67.WanSYiQFanSLvJZhangXGuoLet al.Relationships among lymphocyte subsets,"/>
 <result pre="Autoimmun. 2020;111. 67.WanSYiQFanSLvJZhangXGuoLet al.Relationships among lymphocyte subsets, cytokines, and the" exact="pulmonary" post="inflammation index in coronavirus (covid-19) infected patientsBr J Haematol202018942843732297671"/>
 <result pre="of the scienceImmunity20205291094132505227 69.AnderssonUOttestadWTraceyKJExtracellular hmgb1: a therapeutic target in severe" exact="pulmonary" post="inflammation including covid-19?Mol Med202026113 70.RohJSSohnDHDamage-associated molecular patterns in inflammatory"/>
 <result pre="inflammatory diseasesImmune Netw201818e2730181915 71.ZemskovaMKurdyukovSJamesJMcClainNRafikovRRafikovaOSex-specific stress response and hmgb1 release in" exact="pulmonary" post="endothelial cellsPLoS One202015e023126732271800 72.GhoshSKleinRSSex drives dimorphic immune responses to"/>
 <result pre="pulmonary endothelial cellsPLoS One202015e023126732271800 72.GhoshSKleinRSSex drives dimorphic immune responses to" exact="viral" post="infectionsJ Immunol20171981782179028223406 73.PhoenixCHGoyRWGerallAAYoungWCOrganizing action of prenatally administered testosterone propionate"/>
 <result pre="testosterone propionate on the tissues mediating mating behavior in the" exact="female" post="guinea pigEndocrinology19596536938214432658 74.KoopmanPSex determination: a tale of two sox"/>
 <result pre="tale of two sox genesTrends Genet20052136737015949865 75.ArnoldAPBurgoynePSAre xx and xy" exact="brain" post="cells intrinsically different?Trends Endocrinol Metab20041561114693420 76.NilssonSMakelaSTreuterETujagueMThomsenJAnderssonGet al.Mechanisms of estrogen"/>
 <result pre="signaling pathwaysCell Immunol2015294636925682174 78.PhielKLHendersonRAAdelmanSJEllosoMMDifferential estrogen receptor gene expression in human" exact="peripheral" post="blood mononuclear cell populationsImmunol Lett20059710711315626482 79.PierdominiciMMaselliAColasantiTGiammarioliAMDelunardoFVacircaDet al.Estrogen receptor profiles"/>
 <result pre="mononuclear cell populationsImmunol Lett20059710711315626482 79.PierdominiciMMaselliAColasantiTGiammarioliAMDelunardoFVacircaDet al.Estrogen receptor profiles in human" exact="peripheral" post="blood lymphocytesImmunol Lett2010132798520542061 80.NakadaDOguroHLeviBPRyanNKitanoASaitohYet al.Oestrogen increases haematopoietic stem-cell self-renewal"/>
 <result pre="inhibiting t-helper 1 differentiation. 2014;111:9887â€&quot;92. 82.MuehlenbeinMPCogswellFBJamesMAKoterskiJLudwigGVTestosterone correlates with venezuelan equine" exact="encephalitis" post="virus infection in macaquesVirol J200631916571136 83.FurmanDHejblumBPSimonNJojicVDekkerCLThiÃ©bautRet al.Systems analysis of"/>
 <result pre="t-helper 1 differentiation. 2014;111:9887â€&quot;92. 82.MuehlenbeinMPCogswellFBJamesMAKoterskiJLudwigGVTestosterone correlates with venezuelan equine encephalitis" exact="virus infection" post="in macaquesVirol J200631916571136 83.FurmanDHejblumBPSimonNJojicVDekkerCLThiÃ©bautRet al.Systems analysis of sex differences"/>
 <result pre="1 differentiation. 2014;111:9887â€&quot;92. 82.MuehlenbeinMPCogswellFBJamesMAKoterskiJLudwigGVTestosterone correlates with venezuelan equine encephalitis virus" exact="infection" post="in macaquesVirol J200631916571136 83.FurmanDHejblumBPSimonNJojicVDekkerCLThiÃ©bautRet al.Systems analysis of sex differences"/>
 <result pre="mitigates tolerance to a prostate/prostate cancer-restricted antigenCancer Cell2005723924915766662 85.ViselliSMStanzialeSShultsKKovacsWJOlsenNJCastration alters" exact="peripheral" post="immune function in normal male miceImmunology1995843373427751013 86.Montopoli M, Zumerle"/>
 <result pre="M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for" exact="prostate cancer" post="and risk of infection by sars-cov-2: a population-based study"/>
 <result pre="Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate" exact="cancer" post="and risk of infection by sars-cov-2: a population-based study"/>
 <result pre="et al. Androgen-deprivation therapies for prostate cancer and risk of" exact="infection" post="by sars-cov-2: a population-based study (n = 4532). Ann"/>
 <result pre="protease tmprss2 activates a proteolytic cascade involving components of the" exact="tumor" post="microenvironment and promotes prostate cancer metastasisCancer Discov201441310132525122198 88.SharifiNRyanCJAndrogen hazards"/>
 <result pre="proteolytic cascade involving components of the tumor microenvironment and promotes" exact="prostate cancer" post="metastasisCancer Discov201441310132525122198 88.SharifiNRyanCJAndrogen hazards with covid-19Endocr Relat Cancer202027E1E332302975 89.Baratchian"/>
 <result pre="cascade involving components of the tumor microenvironment and promotes prostate" exact="cancer" post="metastasisCancer Discov201441310132525122198 88.SharifiNRyanCJAndrogen hazards with covid-19Endocr Relat Cancer202027E1E332302975 89.Baratchian"/>
 <result pre="S, et al. 2020. No evidence that androgen regulation of" exact="pulmonary" post="tmprss2 explains sex-discordant covid-19 outcomes.2020.2004.2021.051201. 90.StopsackKHMucciLAAntonarakisESNelsonPSKantoffPWTmprss2 and covid-19: serendipity"/>
 <result pre="intervention?Cancer Discov20201077978232276929 91.PeretzJPekoszALaneAPKleinSLEstrogenic compounds reduce influenza A virus replication in" exact="primary" post="human nasal epithelial cells derived from female, but not"/>
 <result pre="compounds reduce influenza A virus replication in primary human nasal" exact="epithelial" post="cells derived from female, but not male, donorsAm J"/>
 <result pre="characteristics and results of semen tests among men with coronavirus" exact="disease" post="2019JAMA Netw Open20203e20829232379329 96.FagerbergLHallstromBMOksvoldPKampfCDjureinovicDOdebergJet al.Analysis of the human tissue-specific"/>
 <result pre="L, Mao Y, Xiong Y, et al. Effect of sars-cov-2" exact="infection" post="upon male gonadal function: a single center-based study. MedRxiv."/>
 <result pre="study. MedRxiv. 2020; 2020.2003.2021.20037267. 98.XuJQiLHChiXHYangJJWeiXHGongECet al.Orchitis: a complication of severe" exact="acute" post="respiratory syndrome (SARS)Biol Reprod20067441041616237152 99.HanHJWenHLZhouCMChenFFLuoLMLiuJWet al.Bats as reservoirs of"/>
 <result pre="MedRxiv. 2020; 2020.2003.2021.20037267. 98.XuJQiLHChiXHYangJJWeiXHGongECet al.Orchitis: a complication of severe acute" exact="respiratory" post="syndrome (SARS)Biol Reprod20067441041616237152 99.HanHJWenHLZhouCMChenFFLuoLMLiuJWet al.Bats as reservoirs of severe"/>
 <result pre="2020; 2020.2003.2021.20037267. 98.XuJQiLHChiXHYangJJWeiXHGongECet al.Orchitis: a complication of severe acute respiratory" exact="syndrome" post="(SARS)Biol Reprod20067441041616237152 99.HanHJWenHLZhouCMChenFFLuoLMLiuJWet al.Bats as reservoirs of severe emerging"/>
 <result pre="syndrome (SARS)Biol Reprod20067441041616237152 99.HanHJWenHLZhouCMChenFFLuoLMLiuJWet al.Bats as reservoirs of severe emerging" exact="infectious" post="diseasesVirus Res20152051625997928 100.Liu KA, Dipietro Mager NAJPP. Womenâ€™s involvement"/>
</results>
